Search Results

Tumor hypoxia is characterized by extremely low levels of oxygen (<15.2 mmHg/2% O2). It occurs in fifty percent1 of all tumors and is a well-established negative prognostic indicator. Poor outcomes are seen in patients with hypoxic tumors in cancers including breast, cervical, head and neck, soft... More

The idea of storing information using DNA has been around for a while. It’s just that the cost of DNA synthesis has been a bottle neck. What CATALOG is building can be thought of as a printing press with movable typefaces. Instead of having to synthesize billions of different molecules, we are... More

DeepCure develops disruptive Artificial Intelligence technology to revolutionize pharmaceutical development. The pharma industry is undoubtedly one of the world's largest, with worldwide revenues topping one trillion US dollars. However, its effectiveness is in question, as the exponentially... More

Kytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... More